ERICA TAYLOR: Open Payments
NPI 1457570822 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 111 payments from 19 companies in 2025. Trend: 2023 $290 · 2024 $1,502 · 2025 $2,118
Food & beverage: $2,118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $593 |
| Axsome Therapeutics, Inc. | 12 | $298 |
| Otsuka America Pharmaceutical, Inc. | 16 | $274 |
| Vanda Pharmaceuticals Inc. | 10 | $222 |
| Supernus Pharmaceuticals, Inc. | 8 | $154 |
| Janssen Pharmaceuticals, Inc | 6 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Almatica Pharma LLC | 2 | $50 |
| Neos Therapeutics, LP | 2 | $39 |
Products named: VRAYLAR, Auvelity, REXULTI, HETLIOZ, Qelbree, SPRAVATO, CAPLYTA, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
